05 Bophelo bo botle ba pelo - 'maraka oa boemo bo holimo ka tšehetso ea bongaka
Li-supplement tsa pelo li na le karolo ea bobeli e kholo ka ho fetisisa ea chelete ea thekiso ea tlhokomelo ea bophelo lefatšeng ka bophara 'me ke sehlopha se seng se holile, sa nako e telele, se pharaletseng se nang le thepa e phahameng haholo.Omega-3,Coenzyme Q10 leArginine marakeng Mokhoa oa karolo ena, haholo-holo linaheng tse tsoetseng pele, o ntse o hōla 'marakeng oa maemo a holimo ke lihlahisoa tse tšehetsoeng ke tleliniki tse nang le metsoako e tsoetseng pele ea branded.
Lisebelisoa tse tala tse tloaelehileng:Rke llileOmega-3,Nattokinase,COenzyme Q10,OhoBle-glucan,Rsveratrol,INitamine E,INvithamine K2,Spirulina
06 Anti-aging Cognitive Health-Mmaraka o chesang ka ho fetisisa o hōlang ka potlako
Khahlanong le botsofali e bua ka ho hatisoa le ho feta khahlanong le botsofali, eseng feela ho phehella bophelo bo bolelele, empa hape le ho phehella mokhoa oa bophelo bo botle, tabeng ea bophelo bo botle, ho se na lefu kapa bokooa, butle-butle botsofali le ho feta ha nako. . Ka ntlafatso e tsoelang pele ea mohopolo oa tšebeliso ea batho le tlhokomeliso ea bophelo bo botle, tlhokomeliso ea ho thibela botsofali e matlafatsoa butle-butle, sehlopha se khahlanong le botsofali se ntse se le monyenyane, 'me tlhokahalo ea ho thibela botsofali e ntse e eketseha. Batho ba tla sebelisa lihlahisoa tsa tlhokomelo ea letlalo le botle ba bongaka ho boloka ponahalo ea bona ea bocha. Lihlahisoa tsa tlhokomelo ea bophelo botsofali le mekhoa ea boikoetliso le mekhoa ea boikoetliso ho ntlafatsa mesebetsi ea hau ea 'mele.
Lisebelisoa tse tala tse tloaelehileng: NAD+, Pyrroloquinoline quinone,Urolithin A,Spermidine,Fisetin, Phosphatidylserine, Nervonic Acid, Huperzine-A, Resveratrol, 7,8-Dihydroxyflavone, Coenzyme Q10, Cycloastragenol.
Xi'an Healthway Biotech Company Ltd
Mohala: 86 029 81109069
Mobile Phone: 86 18691558819
Irene@xahealthway.com
www.xahealthway.com
https://healthway.en.alibaba.com/
Wechat: 18691558819
WhatsApp: 86 18691558819
Nako ea poso: Jul-19-2023
